Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Acquisition

15 Dec 2017 14:02

RNS Number : 5372Z
Kingspan Group PLC
15 December 2017
Β 

Kingspan Group plc

Acquisition

Β 

15 December 2017

Β 

Further to the Investment Update announced earlier today (RNS 5364Z), Kingspan Group plc ("Kingspan") now provides the following additional information in relation to the acquisition of the Synthesia group:

Β 

Β 

Β· The Synthesia group comprises Synthesia Espanola S.A., Poliuretanos S.A., Huurre Iberica S.A. and their subsidiaries.

Β 

Β· The acquisition agreement which was entered into today, 15 December 2017, with Monsax S.L., Isoblok S.L., Inversiones Landa S.A. and others, is conditional on regulatory clearance and is expected to complete during the first quarter of 2018.Β 

Β 

Β· The total consideration payable by Kingspan for the businesses will be €250m inclusive of debt, which will be satisfied in cash and by the assumption of debt, with €30m of the consideration deferred until 2019. There is an additional €16m consideration being off-set against assets retained by the vendors.Β 

Β 

Β· Gross assets at 31 December 2016 were €180m.

Β 

Β· The acquisition is expected to enhance earnings by circa 6 cent on an annualised basis.

Β 

Β· The existing Synthesia management teams will be retained in the businesses.

Β 

Β 

Β 

For further information contact:

Β 

Β 

Kingspan

Lorcan Dowd, Group Company Secretary

Β 

+353 42 9698000

Murray Consultants

Douglas Keatinge

+353 1 4980300

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQEADASFSDXFFF
Date   Source Headline
7th Mar 20173:57 pmRNSAnnual Financial Report
6th Mar 20177:00 amRNSMain Securities Market Notice
1st Mar 20175:38 pmRNSDirector/PDMR Shareholding
1st Mar 20179:49 amRNSDirector/PDMR Shareholding
1st Mar 20179:30 amRNSTotal Voting Rights
27th Feb 20174:32 pmRNSDirector/PDMR Shareholding
23rd Feb 201710:20 amRNSBlock Listing Application
22nd Feb 20173:04 pmRNSDirector/PDMR Shareholding
20th Feb 20174:36 pmRNSDirector/PDMR Shareholding
20th Feb 201712:32 pmRNSDirector/PDMR Shareholding
17th Feb 20171:51 pmRNSHolding(s) in Company
17th Feb 20177:00 amRNSFinal Results
24th Jan 201712:04 pmRNSNotice of Results
18th Jan 201711:19 amRNSHolding(s) in Company
3rd Jan 20179:45 amRNSHolding(s) in Company
3rd Jan 20179:30 amRNSBlock listing Interim Review
3rd Jan 20177:00 amRNSTotal Voting Rights
14th Dec 20165:02 pmRNSHolding(s) in Company
12th Dec 20164:09 pmRNSHolding(s) in Company
1st Dec 20162:28 pmRNSTotal Voting Rights
29th Nov 20162:30 pmRNSHolding(s) in Company
23rd Nov 20165:04 pmRNSHolding(s) in Company
21st Nov 20162:33 pmRNSDirector/PDMR Shareholding
16th Nov 20165:07 pmRNSCompletion of US private placement
16th Nov 20162:44 pmRNSHolding(s) in Company
14th Nov 20167:00 amRNSTrading Update
10th Nov 20163:04 pmRNSHolding(s) in Company
8th Nov 201611:08 amRNSHolding(s) in Company
1st Nov 20161:15 pmRNSTotal Voting Rights
21st Oct 201612:46 pmRNSHolding(s) in Company
3rd Oct 20161:27 pmRNSTotal Voting Rights
26th Sep 201610:01 amRNSHolding(s) in Company
1st Sep 20163:39 pmRNSDirector/PDMR Shareholding
1st Sep 201611:00 amRNSTotal Voting Rights
25th Aug 20164:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20167:00 amRNSHalf-year Report
2nd Aug 201610:10 amRNSHolding(s) in Company
27th Jul 20165:39 pmRNSHolding(s) in Company
25th Jul 20165:09 pmRNSHolding(s) in Company
14th Jul 20162:18 pmRNSHolding(s) in Company
1st Jul 20164:43 pmRNSHolding(s) in Company
1st Jul 20169:15 amRNSBlock listing Interim Review
1st Jul 20169:00 amRNSTotal Voting Rights
28th Jun 201610:21 amRNSHolding(s) in Company
10th Jun 20163:15 pmRNSHolding(s) in Company
1st Jun 20169:57 amRNSTotal Voting Rights
24th May 20165:02 pmRNSDirector/PDMR Shareholding
20th May 20164:28 pmRNSDirector/PDMR Shareholding
19th May 20164:25 pmRNSDirector/PDMR Shareholding
12th May 20162:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.